角膜曲率计
圆锥角膜
眼科
置信区间
医学
布里氏评分
逻辑回归
数学
回归
人工智能
Lasso(编程语言)
校准
计算器
算法
线性回归
图表
回归分析
核医学
统计
角膜地形图
角膜
范畴变量
接收机工作特性
队列
超参数
特征选择
审查
混淆
作者
Ti Wu,Yang Liu,Xueqian Cao,Yuting Gong,Yujie Jiang,Jin Huang,Zhongguo Li,Junxin Ma,Jing Wang
标识
DOI:10.1016/j.pdpdt.2026.105663
摘要
PURPOSE: To develop and internally validate an interpretable model of keratoconus progression after accelerated corneal cross-linking (A-CXL), emphasizing the thinnest corneal thickness-to-maximum keratometry ratio (TCT/Kmax). METHODS: This retrospective cohort included 170 eyes treated with A-CXL; progression was an increase in maximum keratometry of at least 1.00 D within 1 year. Twenty-six baseline clinical, treatment, and Pentacam-derived tomographic predictors were evaluated using fully nested stratified cross-validation with 10 outer and five inner folds. Scaling, categorical one-hot encoding, 1-SE LASSO selection, hyperparameter tuning, and fitting were confined to each outer training set. Eight algorithms were compared using pooled out-of-fold (OOF) predictions. Discrimination, calibration, clinical utility, and OOF SHAP explanations were assessed. RESULTS: Of 170 eyes, 42 (24.7%) progressed. TCT/Kmax was selected in all 10 outer folds, whereas Km front and BAD-D were each selected in seven. The fold-specific logistic regression (LR) pipeline had the highest candidate-specific OOF AUC (0.772; 95% CI, 0.692-0.844), with an AUPRC of 0.528 and a Brier score of 0.156. Its calibration intercept was -0.19 (95% CI, -0.51 - 0.20) and slope was 1.15 (95% CI, 0.74-1.65). Confidence intervals overlapped across algorithms. TCT/Kmax had the largest mean absolute OOF SHAP value. A separate post-validation three-factor LR model was fitted after validation for interpretation and a research-only calculator prototype. CONCLUSIONS: Leakage-controlled internal validation identified TCT/Kmax as the most stable predictor and supported LR as a parsimonious candidate pipeline. The fixed three-factor model and accompanying calculator are exploratory research tools and require independent external validation before use in clinical decision-making.
科研通智能强力驱动
Strongly Powered by AbleSci AI